Delivery Order SPE2DB20D3101-SPE2DB25FRKC2
Award Date
5/12/25
Potential Completion Date
5/13/25
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,029.07, is for the delivery of fluticasone-salmeterol 230-21 12GM pharmaceutical products. The contract is a firm fixed-price, non-set-aside, with a completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called Fluticasone-Salmeterol 230-21 12GM. The contract, valued at $2,118.30, has a completion date of January 30, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will deliver this medication from its corporate office located in...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,597.75, is for the delivery of Fluticasone-Salmeterol 230-21 12GM, a pharmaceutical product, with a completion date of April 22, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of fluticasone-salmeterol 230-21 12GM medication. The $28,602.57 firm fixed-price contract has a period of performance through July 26, 2024. AmerisourceBergen, a for-profit organization, is providing these prescription drugs to support military treatment facilities and federal healthcare programs. This award is part of a larger Indefinite...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The order, valued at $1,825.10, is for the supply of fluticasone-salmeterol 115-21 12GM, a pharmaceutical product. The delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication. The contract has a firm fixed price of $2,945.89 and a period of performance through April 17, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
The U.S. Defense Logistics Agency (DLA) awarded a $6,924.36 firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. This delivery order is part of a larger, single award indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp by DLA to provide a comprehensive range of pharmaceutical products and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Fluticasone-Salmeterol 230-21 12GM, a prescription medication. The delivery order has a ceiling value of $5,518.84 and is a firm fixed-price contract with a completion date of September 13, 2024. The contract was not set aside for any specific business type. AmerisourceBergen, through its Corporate Office division, has been awarded...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,455.09, is for the delivery of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2025. Amerisourcebergen Drug Corporation is the prime contractor and there is no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,852.01, is for the supply of Fluticasone-Salmeterol 230-21 12GM, a medication used to treat respiratory conditions. The contract is a firm fixed-price, non-set-aside award with a completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...